Hospital end-of-life care in haematological malignancies.
Yvan BeaussantEtienne DaguindauAdrien ChauchetPhilippe RochigneuxChristophe TournigandRégis AubryLucas MorinPublished in: BMJ supportive & palliative care (2018)
A high proportion of patients who died from haematological malignancies receive specific treatments near the end of life. There is a need for a better and earlier integration of the palliative care approach in the standard practice of haematology. However, substantial variation according to the type of haematological malignancy suggests that the patients should not be considered as one homogeneous group. Implementation of palliative care should account for differences across haematological malignancies.